Molecular phenotypes of colorectal cancer and potential clinical applications - Wikidata - awgldk - TriplyDB

Molecular phenotypes of colorectal cancer and potential clinical applications

Molecular phenotypes of colorectal cancer and potential clinical applications

http://www.wikidata.org/entity/Q26785725

about

Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.Tumor location as a novel high risk parameter for stage II colorectal cancers.The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.Elevated tumor-to-liver uptake ratio (TLR) from (18)F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure.Genetic and epigenetic markers in colorectal cancer screening: recent advances.Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer.CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.Does obesity promote the development of colorectal cancer?Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Dysbiosis of gut microbiota in promoting the development of colorectal cancer.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing.

P2860

Q30234587-4B39BD83-E686-45AF-8E23-840AFCADCE21 Q33821751-8DE604B3-0B33-4A06-865E-DDEB828F0CBA Q33828917-7FEBDAC0-EDB9-4DA6-84AC-DF8303095D83 Q33848422-514B1BE0-4AA2-45F9-A1AF-E7301C63E681 Q36047981-4CE42522-5A35-454B-9E38-6248C6D1045B Q36088484-1BF5E228-1EA8-40D7-A370-923EFA3560D8 Q36148358-FD95AFEA-A1C1-4975-93FD-303B0F5C50D3 Q36547753-F83A9983-FA9D-4E3D-A6A0-072B55CADFBA Q37688202-806D542D-0D12-495F-BB6A-D8584026073F Q37692550-2AA90AEF-C8B7-4865-B869-4FC10687FB3B Q37696586-CEFBECAF-8046-4580-8B3A-5F6C6827CD00 Q38622719-DDBA0553-6100-4384-9F85-6897F4E189F6 Q38639638-CACA4963-A495-4F28-ADC7-3DA860F58BBD Q38676702-47A096FA-9207-406D-9EC7-BC2CF6AF796B Q38730936-852990C6-7B54-4695-8A6D-C5C4A40D4700 Q38783093-536FAE41-CE11-4842-AECE-F7A37247CC64 Q39217446-00C15FA4-AD96-47E2-BFE2-4AF3F6A99D39 Q40060444-C0177FA7-4BE8-4620-9768-2AB6A9CCC438 Q40235695-903F34D3-E0F7-42FF-83A3-AFBB3B655C38 Q40244514-2BBED035-D09A-49CF-A059-4077E7B81715 Q40746149-930EEECC-8D67-4F03-B8A4-55A7BD7BDACA Q41052098-7E9A1EA5-633C-4B0F-BFD0-6BB91C14A34C Q41066289-78BD3BF2-ACB4-4948-A90C-E37E7F69EED5 Q42425640-93541253-4B2A-421B-B9A7-828B8D8DE627 Q45065382-617534C1-A2E0-4632-BE22-E29CE711DEBF Q47169813-7A26E659-6909-4493-8D1C-1814903CA456 Q47171553-DB2E50FA-BC40-4081-BF9F-0E3919E4D7FE Q50043586-BD1DB93C-4928-4E1B-9E0B-7E1C807E8D1D Q50233365-8B87C4BF-BE2E-4BE8-8098-A64510B837F2 Q52320729-00E89535-17BB-4509-B878-D55F0CE86794 Q52598780-64A56F31-0162-41CA-8707-CAA75D695953 Q53601791-CBF58E1D-1FD1-498D-B750-4EF1072672F3 Q55002474-A2C740DB-5B68-47C1-9DAA-A7E1020C9FB4

P2860

Molecular phenotypes of colorectal cancer and potential clinical applications

http://www.wikidata.org/entity/Q26785725

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Molecular phenotypes of colorectal cancer and potential clinical applications

@ast

Molecular phenotypes of colorectal cancer and potential clinical applications

@en

Molecular phenotypes of colorectal cancer and potential clinical applications

@nl

type

label

Molecular phenotypes of colorectal cancer and potential clinical applications

@ast

Molecular phenotypes of colorectal cancer and potential clinical applications

@en

Molecular phenotypes of colorectal cancer and potential clinical applications

@nl

prefLabel

Molecular phenotypes of colorectal cancer and potential clinical applications

@ast

Molecular phenotypes of colorectal cancer and potential clinical applications

@en

Molecular phenotypes of colorectal cancer and potential clinical applications

@nl

P1433

Q26785725-F75951A2-19A9-436E-A476-2A0EADC745F3

P1476

Q26785725-D8747CF2-9CB1-4D25-AA39-FED97A0424DE

P2093

Q26785725-04E01AD9-7F7C-4B21-BDC0-2301BD64904E

Q26785725-9961BCEB-F467-4F7D-8C83-46DFF5EF40E2

Q26785725-C81A63EB-4935-46A1-A514-ABD25F586C32

P2860

Q26785725-0055E287-3089-4121-A99D-C6E1B9623026

Q26785725-078866CB-392E-4BF2-9BCE-573154BF20A9

Q26785725-0E5863A4-8BC4-4FA4-B9E6-0662E63957F4

Q26785725-0E748789-F3C7-44EF-BDB1-F5A6C8CAEB8B

Q26785725-1071B509-3967-473A-A9C0-0359C75E990E

Q26785725-115B29E0-A37A-4AA5-96BA-C418EE8C5305

Q26785725-1288BEC4-2541-40CA-BBD7-409A15E5EDDB

Q26785725-13B1E060-93DD-483A-8AE2-6F11CEAA6034

Q26785725-1A3BD7D4-3A06-4402-8895-9C8B425D982D

Q26785725-1A7EC46C-31FB-4626-99B5-0A74B9B406D6

P304

Q26785725-8FCF264F-6C82-4661-81B8-7E1960A2288B

P31

Q26785725-55ED3810-1FD9-4669-BDF1-02B9B86EA19D

P3181

Q26785725-71824EBF-C497-4957-8519-431C1120594C

P356

Q26785725-2ECDBBE7-9299-409C-A5E4-F2E494D50DD2

P407

Q26785725-31BA1543-1C21-46D4-82F6-2A596A39BDFC

P433

Q26785725-11408FE9-55B4-436F-A393-F5ED507B0A9F

P478

Q26785725-FD4A81AF-D490-4595-8632-428271067196

P577

Q26785725-73B881CA-CD42-471C-8C26-C9F81448DCF5

P5875

Q26785725-A225170E-5EC6-4615-9692-416805B3F03C

P698

Q26785725-1D187900-1195-4614-93EB-DE0C08675757

P921

Q26785725-35182253-573F-4808-8EF9-4913D3641DCC

P932

Q26785725-2B960739-DDCE-41AF-B967-77A351AC501E

P3181

P356

P1433

Gastroenterology report

P1476

Molecular phenotypes of colorectal cancer and potential clinical applications

@en

P2093

Amanda I Phipps

http://www.w3.org/2001/XMLSchema#string

Jonathan M Kocarnik

http://www.w3.org/2001/XMLSchema#string

Stacey Shiovitz

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

Comprehensive molecular characterization of human colon and rectal cancer

AKT/PKB signaling: navigating downstream

CpG island methylator phenotype in colorectal cancer

PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

P304

269-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

880612

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/GASTRO/GOV046

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281513889

http://www.w3.org/2001/XMLSchema#string

P698

26337942

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4650976

http://www.w3.org/2001/XMLSchema#string